Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol in Vasospastic Angina (STELLA Extension)
NCT02094469Phase 3Completed
- Sponsor
- Otsuka Holdings
- Start
- Dec 2013
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cilostazol in vasospastic angina (VSA), sponsored by Otsuka Holdings. Started Dec 2013; status: completed.
02
Drugs
cilostazol
03
Conditions
vasospastic angina (VSA)
Beyond the preview
Go deeper on NCT02094469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02094469.